# Oral Dosage Form New Animal Drugs; Toceranib
> **Food and Drug Administration** · Final rule. · Published 2009-06-18 · Effective 2009-06-18 · 74 FR 28874
## Document
- **Document number:** E9-14299
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 28874
- **CFR reference:** 21 CFR 520
- **Publication date:** 2009-06-18
- **Effective date:** 2009-06-18
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the original approval of a new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of toceranib phosphate tablets in dogs for treatment of recurrent, cutaneous mast cell tumors.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/06/18/E9-14299/oral-dosage-form-new-animal-drugs-toceranib)
---
*AI Analytics · CC0 1.0*